Takahashi, O., Komaki, R., Smith, P., Ryan, A., Jurgensmeier, J., Welsh, J., Jacoby, J., Hosho, K., Korshunova, M., Erez, B., Herbst, R., & O'Reilly, M. S. (2016). MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib. JOURNAL OF THORACIC ONCOLOGY, 4(9), S593–S593.

Takahashi, O., et al. “MEK1/2 Blockade by AZD6244 (ARRY-142886) Inhibits Tumor Growth and Progression in an Orthotopic Human Lung Adenocarcinoma Model with Enhanced Efficacy When Combined with Cediranib.” JOURNAL OF THORACIC ONCOLOGY, vol. 4, no. 9, 2016, pp. S593–S593.

Takahashi, O, R Komaki, P Smith, A Ryan, J Jurgensmeier, J Welsh, J Jacoby, et al. 2016. “MEK1/2 Blockade by AZD6244 (ARRY-142886) Inhibits Tumor Growth and Progression in an Orthotopic Human Lung Adenocarcinoma Model with Enhanced Efficacy When Combined with Cediranib.” JOURNAL OF THORACIC ONCOLOGY 4 (9): S593–S593.